These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9379436)

  • 21. Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.
    Portevin B; Lonchampt M; Canet E; De Nanteuil G
    J Med Chem; 1997 Jun; 40(12):1906-18. PubMed ID: 9191969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A leukocyte elastase inhibitor reduces thrombin-induced pulmonary oedema in the rat: mechanisms of action.
    Ahn CM; Sandler H; Saldeen T
    Pulm Pharmacol Ther; 1998; 11(4):291-9. PubMed ID: 10101747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase.
    Shreder KR; Cajica J; Du L; Fraser A; Hu Y; Kohno Y; Lin EC; Liu SJ; Okerberg E; Pham L; Wu J; Kozarich JW
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4743-6. PubMed ID: 19577470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-Acylamino-2-[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based inhibitors of human leukocyte elastase.
    Kerrigan JE; Walters MC; Forrester KJ; Crowder JB; Christopher LJ
    Bioorg Med Chem Lett; 2000 Jan; 10(1):27-30. PubMed ID: 10636236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alternative synthesis of peptidyl alpha-keto-2-oxazolines.
    Dunn D; Chatterjee S
    Bioorg Med Chem Lett; 1998 May; 8(10):1273-6. PubMed ID: 9871748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of orally active nonpeptidic inhibitors of human neutrophil elastase.
    Ohmoto K; Yamamoto T; Okuma M; Horiuchi T; Imanishi H; Odagaki Y; Kawabata K; Sekioka T; Hirota Y; Matsuoka S; Nakai H; Toda M; Cheronis JC; Spruce LW; Gyorkos A; Wieczorek M
    J Med Chem; 2001 Apr; 44(8):1268-85. PubMed ID: 11312926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.
    Iwanowicz EJ; Kimball SD; Lin J; Lau W; Han WC; Wang TC; Roberts DG; Schumacher WA; Ogletree ML; Seiler SM
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3183-6. PubMed ID: 12372529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles.
    Velázquez F; Sannigrahi M; Bennett F; Lovey RG; Arasappan A; Bogen S; Nair L; Venkatraman S; Blackman M; Hendrata S; Huang Y; Huelgas R; Pinto P; Cheng KC; Tong X; McPhail AT; Njoroge FG
    J Med Chem; 2010 Apr; 53(8):3075-85. PubMed ID: 20302300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and elastase inhibition activities of novel aryl, substituted aryl, and heteroaryl oxime ester derivatives.
    Hasdemir B; Sacan O; Yasa H; Kucuk HB; Yusufoglu AS; Yanardag R
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29251374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors.
    Cantini N; Crocetti L; Guerrini G; Vergelli C; Schepetkin IA; Pallecchi M; Bartolucci G; Quinn MT; Teodori E; Giovannoni MP
    Bioorg Med Chem Lett; 2021 Nov; 52():128380. PubMed ID: 34563669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
    Charlton J; Kirschenheuter GP; Smith D
    Biochemistry; 1997 Mar; 36(10):3018-26. PubMed ID: 9062133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orally bioavailable benzisothiazolone inhibitors of human leukocyte elastase.
    Hlasta DJ; Subramanyam C; Bell MR; Carabateas PM; Court JJ; Desai RC; Drozd ML; Eickhoff WM; Ferguson EW; Gordon RJ
    J Med Chem; 1995 Mar; 38(5):739-44. PubMed ID: 7877139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-peptidic inhibitors of human leukocyte elastase. 4. Design, synthesis, and in vitro and in vivo activity of a series of beta-carbolinone-containing trifluoromethyl ketones.
    Veale CA; Damewood JR; Steelman GB; Bryant C; Gomes B; Williams J
    J Med Chem; 1995 Jan; 38(1):86-97. PubMed ID: 7837244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serendipitous discovery of an unexpected rearrangement leads to two new classes of potential protease inhibitors.
    Zhong J; Lai Z; Groutas CS; Wong T; Gan X; Alliston KR; Eichhorn D; Hoidal JR; Groutas WC
    Bioorg Med Chem; 2004 Dec; 12(23):6249-54. PubMed ID: 15519167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase--GW311616A a development candidate.
    Macdonald SJ; Dowle MD; Harrison LA; Shah P; Johnson MR; Inglis GG; Clarke GD; Smith RA; Humphreys D; Molloy CR; Amour A; Dixon M; Murkitt G; Godward RE; Padfield T; Skarzynski T; Singh OM; Kumar KA; Fleetwood G; Hodgson ST; Hardy GW; Finch H
    Bioorg Med Chem Lett; 2001 Apr; 11(7):895-8. PubMed ID: 11294386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of orally active, non-peptidic inhibitors of human leukocyte elastase.
    Brown FJ; Andisik DW; Bernstein PR; Bryant CB; Ceccarelli C; Damewood JR; Edwards PD; Earley RA; Feeney S; Green RC
    J Med Chem; 1994 Apr; 37(9):1259-61. PubMed ID: 8176703
    [No Abstract]   [Full Text] [Related]  

  • 38. Syntheses of trans-5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles and trans-5-oxo-hexahydro-furo[3,2-b]pyrroles (pyrrolidine trans-lactams and trans-lactones): new pharmacophores for elastase inhibition.
    Macdonald SJ; Belton DJ; Buckley DM; Spooner JE; Anson MS; Harrison LA; Mills K; Upton RJ; Dowle MD; Smith RA; Molloy CR; Risley C
    J Med Chem; 1998 Oct; 41(21):3919-22. PubMed ID: 9767628
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and synthesis of factor Xa inhibitors and their prodrugs.
    Song Y; Clizbe L; Bhakta C; Teng W; Wong P; Huang B; Tran K; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Jan; 13(2):297-300. PubMed ID: 12482444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and anti-elastase properties of 6-amino-2-phenyl-4H-3,1-benzoxazin-4-one aminoacyl and dipeptidyl derivatives.
    Colson E; Wallach J; Hauteville M
    Biochimie; 2005 Feb; 87(2):223-30. PubMed ID: 15760716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.